Study of Belatacept in Subjects Who Are Undergoing a Renal Transplant
Public ClinicalTrials.gov record NCT00114777. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial - Extended Criteria Donors (BENEFIT-EXT)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this trial is to learn if Belatacept is effective and safe as a first line of immunosuppression treatment in patients undergoing a renal transplant where the donor kidney is obtained in patients with extended criteria.
Study identification
- NCT ID
- NCT00114777
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 595 participants
Conditions and interventions
Conditions
Interventions
- Cyclosporin A Drug
- Belatacept Less Intensive Regimen (LI) Drug
- Belatacept More Intensive Regimen (MI) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2005 (Type not available)
- Primary completion
- May 2008 (Actual)
- Completion
- Sep 2014 (Actual)
- Last update posted
- Jul 7, 2017
2005 – 2014
United States locations
- U.S. sites
- 28
- U.S. states
- 17
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University Of Alabama At Birmingham | Birmingham | Alabama | 35294 | — |
| Ucla Kidney & Kidney-Pancreas Transplant Research Office | Los Angeles | California | 90024 | — |
| National Institute Of Transplantation | Los Angeles | California | 90057 | — |
| Sharp Memorial Hospital | San Diego | California | 92133 | — |
| University Of California San Francisco Medical Center | San Francisco | California | 94143 | — |
| University Of Colorado Health Sciences Center | Aurora | Colorado | 80045 | — |
| Yale University School Of Medicine | New Haven | Connecticut | 06540 | — |
| Lifelink Healthcare Institute | Tampa | Florida | 33606 | — |
| Piedmont Transplant Institute | Atlanta | Georgia | 30309 | — |
| Emory University Hospital | Atlanta | Georgia | 30322 | — |
| Northwestern University-Feinberg School Of Medicine | Chicago | Illinois | 60611 | — |
| University Of Chicago Hospitals | Chicago | Illinois | 60637 | — |
| Acadiana Renal Physicians | New Iberia | Louisiana | 70563 | — |
| Tulane Abdominal Transplant Institute | New Orleans | Louisiana | 70112 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | — |
| Western New England Renal & Transplant Associates, Pc | Springfield | Massachusetts | 01107 | — |
| Henry Ford Hospital, Transplant Institute | Detroit | Michigan | 48202 | — |
| University Of Minnesota | Minneapolis | Minnesota | 55455 | — |
| Washington University School Of Medicine | St Louis | Missouri | 63110 | — |
| Mount Sinai School Of Medicine | New York | New York | 10029 | — |
| Columbia University College Of Physicians & Surgeons | New York | New York | 10032 | — |
| University Of North Carolina At Chapel Hill | Chapel Hill | North Carolina | 27599 | — |
| Carolinas Medical Center | Charlotte | North Carolina | 28203 | — |
| Drexel University College Of Medicine, Department Of Surgery | Philadelphia | Pennsylvania | 19102 | — |
| University Of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Baylor University Medical Center | Dallas | Texas | 75246 | — |
| University Of Wisconsin | Madison | Wisconsin | 53792 | — |
| Froedtert Memorial Hospital | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 51 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00114777, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 7, 2017 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00114777 live on ClinicalTrials.gov.